{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:33:03Z","timestamp":1793817183838,"version":"4.6.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01631-9","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T05:42:50Z","timestamp":1747460570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Microglial activation as a hallmark of neuroinflammation in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0991-7752","authenticated-orcid":false,"given":"Rasoul","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6865-3481","authenticated-orcid":false,"given":"Shahrzad","family":"Shahrokhi Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-5466","authenticated-orcid":false,"given":"Mahdi","family":"Falah Tafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5051-9124","authenticated-orcid":false,"given":"Zahra","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2918-9356","authenticated-orcid":false,"given":"Seyyedeh Reyhaneh","family":"Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9896-9752","authenticated-orcid":false,"given":"Dana","family":"Ramadhan Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7304-3621","authenticated-orcid":false,"given":"Niki","family":"Talebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-9285","authenticated-orcid":false,"given":"Khadijeh","family":"Esmaeilpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"1631_CR2","doi-asserted-by":"crossref","unstructured":"Abels ER, Nieland L, Hickman S, Broekman MLD, El Khoury J, Maas SLN (2021) Comparative analysis identifies similarities between the human and murine microglial sensomes. Int J Mol Sci 22","DOI":"10.3390\/ijms22031495"},{"key":"1631_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/glia.23265","volume":"66","author":"S Alawieyah Syed Mortadza","year":"2018","unstructured":"Alawieyah Syed Mortadza S, Sim JA, Neubrand VE, Jiang LH (2018) A critical role of TRPM2 channel in A\u03b2(42) -induced microglial activation and generation of tumor necrosis factor-\u03b1. Glia 66:562\u2013575","journal-title":"Glia"},{"key":"1631_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.0000000000001859","volume":"85","author":"D Alcolea","year":"2015","unstructured":"Alcolea D et al (2015) Amyloid precursor protein metabolism and inflammation markers in preclinical alzheimer disease. Neurology 85:626\u2013633","journal-title":"Neurology"},{"key":"1631_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.intimp.2017.10.024","volume":"54","author":"M Aminzadeh","year":"2018","unstructured":"Aminzadeh M, Roghani M, Sarfallah A, Riazi GH (2018) TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer\u2019s disease. Int Immunopharmacol 54:78\u201385","journal-title":"Int Immunopharmacol"},{"key":"1631_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/cei.13670","volume":"206","author":"S Amor","year":"2021","unstructured":"Amor S, Nutma E, Owen D (2021) Imaging immune responses in neuroinflammatory diseases. Clin Exp Immunol 206:248\u2013250","journal-title":"Clin Exp Immunol"},{"key":"1631_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/dneu.22814","volume":"81","author":"M Andoh","year":"2021","unstructured":"Andoh M, Koyama R (2021) Microglia regulate synaptic development and plasticity. Dev Neurobiol 81:568\u2013590","journal-title":"Dev Neurobiol"},{"key":"1631_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1017\/S1355617721000813","volume":"28","author":"BM Asken","year":"2022","unstructured":"Asken BM, VandeVrede L, Rojas JC, Fonseca C, Staffaroni AM, Elahi FM, Lindbergh CA, Apple AC, You M, Weiner-Light S, Brathaban N, Fernandes N, Boxer AL, Miller BL, Rosen HJ, Kramer JH, Casaletto KB (2022) Lower white matter volume and worse executive functioning reflected in higher levels of plasma GFAP among older adults with and without cognitive impairment. J Int Neuropsychol Soc 28:588\u2013599","journal-title":"J Int Neuropsychol Soc"},{"key":"1631_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.celrep.2016.12.041","volume":"18","author":"K Askew","year":"2017","unstructured":"Askew K, Li K, Olmos-Alonso A, Garcia-Moreno F, Liang Y, Richardson P, Tipton T, Chapman MA, Riecken K, Beccari S, Sierra A, Moln\u00e1r Z, Cragg MS, Garaschuk O, Perry VH, Gomez-Nicola D (2017) Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain. Cell Rep 18:391\u2013405","journal-title":"Cell Rep"},{"key":"1631_CR10","doi-asserted-by":"publisher","first-page":"101339","DOI":"10.1016\/j.arr.2021.101339","volume":"68","author":"KI Avgerinos","year":"2021","unstructured":"Avgerinos KI, Ferrucci L, Kapogiannis D (2021) Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer\u2019s disease. Ageing Res Rev 68:101339","journal-title":"Ageing Res Rev"},{"key":"1631_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3233\/JAD-150705","volume":"50","author":"M Babi\u0107 Leko","year":"2016","unstructured":"Babi\u0107 Leko M, Borove\u010dki F, Dejanovi\u0107 N, Hof PR, \u0160imi\u0107 G (2016) Predictive value of cerebrospinal fluid Visinin-Like Protein-1 levels for Alzheimer\u2019s disease early detection and differential diagnosis in patients with mild cognitive impairment. J Alzheimers Dis 50:765\u2013778","journal-title":"J Alzheimers Dis"},{"key":"1631_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","volume":"30","author":"SH Baik","year":"2019","unstructured":"Baik SH, Kang S, Lee W, Choi H, Chung S, Kim JI, Mook-Jung I (2019) A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer\u2019s disease. Cell Metab 30:493\u2013507e496","journal-title":"Cell Metab"},{"key":"1631_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller SM, McCray TJ, Allan K, Formica SV, Xu G, Wilson G, Kokiko-Cochran ON, Crish SD, Lasagna-Reeves CA, Ransohoff RM (2017) TREM2 deficiency exacerbates Tau pathology through dysregulated kinase signaling in a mouse model of Tauopathy. Mol Neurodegeneration 12:1\u201312","journal-title":"Mol Neurodegeneration"},{"key":"1631_CR14","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL et al (2021) Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum. JAMA Neurol 78:1471\u20131483","journal-title":"JAMA Neurol"},{"key":"1631_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1023\/A:1007056731551","volume":"28","author":"HG Bernstein","year":"1999","unstructured":"Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH (1999) Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 28:655\u2013662","journal-title":"J Neurocytol"},{"key":"1631_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00325030","volume":"85","author":"K Blinzinger","year":"1968","unstructured":"Blinzinger K, Kreutzberg G (1968) Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat 85:145\u2013157","journal-title":"Z Zellforsch Mikrosk Anat"},{"issue":"Suppl 2","key":"1631_CR17","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/1471-2202-9-S2-S8","volume":"9","author":"ML Block","year":"2008","unstructured":"Block ML (2008) NADPH oxidase as a therapeutic target in Alzheimer\u2019s disease. BMC Neurosci 9(Suppl 2):S8","journal-title":"BMC Neurosci"},{"key":"1631_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2006.04.017","volume":"24","author":"K Boekhoorn","year":"2006","unstructured":"Boekhoorn K, Joels M, Lucassen PJ (2006) Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile alzheimer hippocampus. Neurobiol Dis 24:1\u201314","journal-title":"Neurobiol Dis"},{"key":"1631_CR19","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","volume":"72","author":"JC Breitner","year":"2009","unstructured":"Breitner JC, Haneuse SJ, Walker R, Dublin S, Crane PK, Gray SL, Larson EB (2009) Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 72:1899\u20131905","journal-title":"Neurology"},{"key":"1631_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14283\/jpad.2018.18","volume":"5","author":"AH Burstein","year":"2018","unstructured":"Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L (2018) Development of Azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer\u2019s disease. J Prev Alzheimers Dis 5:149\u2013154","journal-title":"J Prev Alzheimers Dis"},{"key":"1631_CR21","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT (2020) Synergy between amyloid-\u03b2 and Tau in Alzheimer\u2019s disease. Nat Neurosci 23:1183\u20131193","journal-title":"Nat Neurosci"},{"key":"1631_CR22","doi-asserted-by":"publisher","first-page":"104956","DOI":"10.1016\/j.nbd.2020.104956","volume":"142","author":"BT Casali","year":"2020","unstructured":"Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE (2020) Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies. Neurobiol Dis 142:104956","journal-title":"Neurobiol Dis"},{"key":"1631_CR23","doi-asserted-by":"crossref","unstructured":"Cs\u00e1sz\u00e1r E et al (2022) Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions. J Exp Med 219","DOI":"10.1084\/jem.20211071"},{"key":"1631_CR24","doi-asserted-by":"publisher","first-page":"e12385","DOI":"10.1002\/trc2.12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023) Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement (N Y) 9:e12385","journal-title":"Alzheimers Dement (N Y)"},{"key":"1631_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12974-015-0366-9","volume":"12","author":"NN Dagher","year":"2015","unstructured":"Dagher NN, Najafi AR, Kayala KM, Elmore MR, White TE, Medeiros R, West BL, Green KN (2015) Colony-stimulating factor 1 receptor Inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J Neuroinflammation 12:139","journal-title":"J Neuroinflammation"},{"key":"1631_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164:603\u2013615","journal-title":"Cell"},{"key":"1631_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/156720507780362245","volume":"4","author":"R Deane","year":"2007","unstructured":"Deane R, Zlokovic BV (2007) Role of the blood-brain barrier in the pathogenesis of Alzheimer\u2019s disease. Curr Alzheimer Res 4:191\u2013197","journal-title":"Curr Alzheimer Res"},{"key":"1631_CR28","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology 29:1669\u20131681","journal-title":"Inflammopharmacology"},{"key":"1631_CR29","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00018-019-03040-5","volume":"76","author":"K Dhiman","year":"2019","unstructured":"Dhiman K, Blennow K, Zetterberg H, Martins RN, Gupta VB (2019) Cerebrospinal fluid biomarkers for Understanding multiple aspects of Alzheimer\u2019s disease pathogenesis. Cell Mol Life Sci 76:1833\u20131863","journal-title":"Cell Mol Life Sci"},{"key":"1631_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","volume":"16","author":"FM Elahi","year":"2020","unstructured":"Elahi FM, Casaletto KB, La Joie R, Walters SM, Harvey D, Wolf A, Edwards L, Rivera-Contreras W, Karydas A, Cobigo Y, Rosen HJ, DeCarli C, Miller BL, Rabinovici GD, Kramer JH (2020) Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement 16:681\u2013695","journal-title":"Alzheimers Dement"},{"key":"1631_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C et al (2021) Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 24:312\u2013325","journal-title":"Nat Neurosci"},{"key":"1631_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.bbrc.2019.06.134","volume":"516","author":"D Feng","year":"2019","unstructured":"Feng D, Huang A, Yan W, Chen D (2019) CD200 dysfunction in neuron contributes to synaptic deficits and cognitive impairment. Biochem Biophys Res Commun 516:1053\u20131059","journal-title":"Biochem Biophys Res Commun"},{"key":"1631_CR33","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","volume":"34","author":"P Forabosco","year":"2013","unstructured":"Forabosco P, Ramasamy A, Trabzuni D, Walker R, Smith C, Bras J, Levine AP, Hardy J, Pocock JM, Guerreiro R (2013) Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging 34:2699\u20132714","journal-title":"Neurobiol Aging"},{"key":"1631_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neubiorev.2016.02.013","volume":"64","author":"B Garc\u00eda Bueno","year":"2016","unstructured":"Garc\u00eda Bueno B, Caso JR, Madrigal JL, Leza JC (2016) Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci Biobehav Rev 64:134\u2013147","journal-title":"Neurosci Biobehav Rev"},{"key":"1631_CR35","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves LA, Rodrigues-Duarte L, Rodo J, Vieira de Moraes L, Marques I, Penha-Gon\u00e7alves C (2013) TREM2 governs Kupffer cell activation and explains belr1 genetic resistance to malaria liver stage infection.\u00a0Proc Natl Acad Sci USA\u00a0110:19531\u201319536","DOI":"10.1073\/pnas.1306873110"},{"key":"1631_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s13167-017-0110-x","volume":"8","author":"I Gozes","year":"2017","unstructured":"Gozes I (2017) Specific protein biomarker patterns for Alzheimer\u2019s disease: improved diagnostics in progress. EPMA J 8:255\u2013259","journal-title":"EPMA J"},{"key":"1631_CR37","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn.2432","volume":"12","author":"SA Grathwohl","year":"2009","unstructured":"Grathwohl SA, K\u00e4lin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, Eldh T, Gandy S, Aguzzi A, Staufenbiel M, Mathews PM, Wolburg H, Heppner FL, Jucker M (2009) Formation and maintenance of Alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12:1361\u20131363","journal-title":"Nat Neurosci"},{"key":"1631_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM (2018) New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegeneration 13:66","journal-title":"Mol Neurodegeneration"},{"issue":"1","key":"1631_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JAD-150060","volume":"47","author":"M Groblewska","year":"2015","unstructured":"Groblewska M, Muszy\u0144ski P, Wojtulewska-Supron A, Kulczy\u0144ska-Przybik A, Mroczko B (2015) The role of Visinin-Like Protein-1 in the pathophysiology of Alzheimer\u2019s disease. J Alzheimer\u2019s Disease: JAD 47(1):17\u201332","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"1631_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ibra.12023","volume":"8","author":"Y-H Guan","year":"2022","unstructured":"Guan Y-H, Zhang L-J, Wang S-Y, Deng Y-D, Zhou H-S, Chen D-Q, Zhang L-C (2022) The role of microglia in Alzheimer\u2019s disease and progress of treatment. Ibrain 8:37\u201347","journal-title":"Ibrain"},{"key":"1631_CR41","doi-asserted-by":"publisher","first-page":"815347","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y (2022) Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci 14:815347","journal-title":"Front Aging Neurosci"},{"key":"1631_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217:459\u2013472","journal-title":"J Cell Biol"},{"key":"1631_CR43","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng T-C (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493:674\u2013678","journal-title":"Nature"},{"key":"1631_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-1-4939-9658-2_23","volume":"2034","author":"SE Hickman","year":"2019","unstructured":"Hickman SE, El Khoury J (2019) Analysis of the microglial sensome. Methods Mol Biol 2034:305\u2013323","journal-title":"Methods Mol Biol"},{"key":"1631_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0006-8993(99)01804-1","volume":"842","author":"J Hu","year":"1999","unstructured":"Hu J, Van Eldik LJ (1999) Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation. Brain Res 842:46\u201354","journal-title":"Brain Res"},{"key":"1631_CR46","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/alz.12851","volume":"19","author":"J Huang","year":"2023","unstructured":"Huang J, Stein TD, Wang Y, Ang TFA, Tao Q, Lunetta KL, Massaro J, Akhter-Khan SC, Mez J, Au R, Farrer LA, Zhang X, Qiu WQ (2023) Blood levels of MCP-1 modulate the genetic risks of Alzheimer\u2019s disease mediated by HLA-DRB1 and APOE for Alzheimer\u2019s disease. Alzheimers Dement 19:1925\u20131937","journal-title":"Alzheimers Dement"},{"key":"1631_CR47","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00004647-200206000-00001","volume":"22","author":"EA Irving","year":"2002","unstructured":"Irving EA, Bamford M (2002) Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631\u2013647","journal-title":"J Cereb Blood Flow Metab"},{"key":"1631_CR48","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.4049\/jimmunol.1102661","volume":"188","author":"MK Jenkins","year":"2012","unstructured":"Jenkins MK, Moon JJ (2012) The role of Naive T cell precursor frequency and recruitment in dictating immune response magnitude. J Immunol 188:4135\u20134140","journal-title":"J Immunol"},{"key":"1631_CR49","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1523\/JNEUROSCI.2620-14.2015","volume":"35","author":"M Kawabori","year":"2015","unstructured":"Kawabori M, Kacimi R, Kauppinen T, Calosing C, Kim JY, Hsieh CL, Nakamura MC, Yenari MA (2015) Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci 35:3384\u20133396","journal-title":"J Neurosci"},{"key":"1631_CR50","doi-asserted-by":"publisher","first-page":"110961","DOI":"10.1016\/j.celrep.2022.110961","volume":"39","author":"S Kiani Shabestari","year":"2022","unstructured":"Kiani Shabestari S et al (2022) Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice. Cell Rep 39:110961","journal-title":"Cell Rep"},{"key":"1631_CR51","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.4049\/jimmunol.179.10.7093","volume":"179","author":"T Kojima","year":"2007","unstructured":"Kojima T, Obata K, Mukai K, Sato S, Takai T, Minegishi Y, Karasuyama H (2007) Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-Independent Manner1. J Immunol 179:7093\u20137100","journal-title":"J Immunol"},{"key":"1631_CR52","doi-asserted-by":"publisher","first-page":"6522","DOI":"10.4049\/jimmunol.0901171","volume":"184","author":"LL Koth","year":"2010","unstructured":"Koth LL, Cambier C, Ellwanger A, Solon M, Hou L, Lanier LL, Abram CL, Hamerman JA, Woodruff PG (2010) DAP12 is required for macrophage recruitment to the lung in response to cigarette smoke and chemotaxis toward CCL2. J Immunol 184:6522\u20136528","journal-title":"J Immunol"},{"key":"1631_CR53","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1126\/science.aba5906","volume":"369","author":"L Kracht","year":"2020","unstructured":"Kracht L, Borggrewe M, Eskandar S, Brouwer N, Chuva de Sousa Lopes SM, Laman JD, Scherjon SA, Prins JR, Kooistra SM, Eggen BJL (2020) Human fetal microglia acquire homeostatic immune-sensing properties early in development. Science 369:530\u2013537","journal-title":"Science"},{"key":"1631_CR54","doi-asserted-by":"publisher","first-page":"C129","DOI":"10.1152\/ajpcell.00331.2003","volume":"286","author":"R Kraft","year":"2004","unstructured":"Kraft R, Grimm C, Grosse K, Hoffmann A, Sauerbruch S, Kettenmann H, Schultz G, Harteneck C (2004) Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am J Physiol Cell Physiol 286:C129\u2013137","journal-title":"Am J Physiol Cell Physiol"},{"key":"1631_CR55","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CYD Lee","year":"2010","unstructured":"Lee CYD, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117:949\u2013960","journal-title":"J Neural Transm"},{"key":"1631_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in alzheimer disease: where do we go from here? Nat Rev Neurol 17:157\u2013172","journal-title":"Nat Rev Neurol"},{"key":"1631_CR57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481\u2013487","journal-title":"Nature"},{"key":"1631_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13578-021-00738-7","volume":"12","author":"JE Luo","year":"2022","unstructured":"Luo JE, Li YM (2022) Turning the tide on Alzheimer\u2019s disease: modulation of \u03b3-secretase. Cell Biosci 12:2","journal-title":"Cell Biosci"},{"key":"1631_CR59","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/brain\/awh655","volume":"129","author":"D Mahad","year":"2006","unstructured":"Mahad D, Callahan MK, Williams KA, Ubogu EE, Kivis\u00e4kk P, Tucky B, Kidd G, Kingsbury GA, Chang A, Fox RJ, Mack M, Sniderman MB, Ravid R, Staugaitis SM, Stins MF, Ransohoff RM (2006) Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain 129:212\u2013223","journal-title":"Brain"},{"key":"1631_CR60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7326\/M21-1687","volume":"175","author":"ER Marcantonio","year":"2022","unstructured":"Marcantonio ER, Fick DM, Jung Y, Inouye SK, Boltz M, Leslie DL, Husser EK, Shrestha P, Moore A, Sulmonte K, Siuta J, Boustani M, Ngo LH (2022) Comparative implementation of a brief App-Directed protocol for delirium identification by hospitalists, nurses, and nursing assistants: A cohort study. Ann Intern Med 175:65\u201373","journal-title":"Ann Intern Med"},{"key":"1631_CR61","doi-asserted-by":"crossref","unstructured":"Merighi S, Nigro M, Travagli A, Gessi S (2022) Microglia and Alzheimer\u2019s Disease. Int J Mol Sci 23","DOI":"10.3390\/ijms232112990"},{"key":"1631_CR62","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/biom10101439","volume":"10","author":"JR Perea","year":"2020","unstructured":"Perea JR, Bol\u00f3s M, Avila J (2020) Microglia in Alzheimer\u2019s disease in the context of Tau pathology. Biomolecules 10:1439","journal-title":"Biomolecules"},{"key":"1631_CR63","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, Zetterberg H, Stomrud E, Ashton NJ, Blennow K, Hansson O (2021) Plasma GFAP is an early marker of amyloid-\u03b2 but not Tau pathology in Alzheimer\u2019s disease. Brain 144:3505\u20133516","journal-title":"Brain"},{"key":"1631_CR64","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2014.10.029","volume":"302","author":"V Porrini","year":"2015","unstructured":"Porrini V, Lanzillotta A, Branca C, Benarese M, Parrella E, Lorenzini L, Calz\u00e0 L, Flaibani R, Spano PF, Imbimbo BP, Pizzi M (2015) CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid. Neuroscience 302:112\u2013120","journal-title":"Neuroscience"},{"key":"1631_CR65","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13195-021-00843-2","volume":"13","author":"ND Prins","year":"2021","unstructured":"Prins ND, Harrison JE, Chu HM, Blackburn K, Alam JJ, Scheltens P (2021) A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer\u2019s disease. Alzheimers Res Ther 13:106","journal-title":"Alzheimers Res Ther"},{"key":"1631_CR66","doi-asserted-by":"crossref","unstructured":"Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines.\u00a0Sci World J\u00a02012:756357","DOI":"10.1100\/2012\/756357"},{"key":"1631_CR67","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1016\/j.ygeno.2021.07.001","volume":"113","author":"MS Saddala","year":"2021","unstructured":"Saddala MS, Yang X, Tang S, Huang H (2021) Transcriptome-wide analysis reveals core sets of transcriptional regulators of sensome and inflammation genes in retinal microglia. Genomics 113:3058\u20133071","journal-title":"Genomics"},{"key":"1631_CR68","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/acn3.549","volume":"5","author":"P Scheltens","year":"2018","unstructured":"Scheltens P, Prins N, Lammertsma A, Yaqub M, Gouw A, Wink AM, Chu HM, van Berckel BNM, Alam J (2018) An exploratory clinical study of p38\u03b1 kinase Inhibition in Alzheimer\u2019s disease. Ann Clin Transl Neurol 5:464\u2013473","journal-title":"Ann Clin Transl Neurol"},{"key":"1631_CR69","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.ajpath.2013.02.031","volume":"182","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo A, G\u00f3mez-Isla T, Growdon JH, Frosch MP, Hyman BT (2013) A phenotypic change but not proliferation underlies glial responses in alzheimer disease. Am J Pathol 182:2332\u20132344","journal-title":"Am J Pathol"},{"key":"1631_CR70","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/eji.201545855","volume":"46","author":"S Shi","year":"2016","unstructured":"Shi S, Liang D, Chen Y, Xie Y, Wang Y, Wang L, Wang Z, Qiao Z (2016) Gx-50 reduces \u03b2-amyloid-induced TNF-\u03b1, IL-1\u03b2, NO, and PGE2 expression and inhibits NF-\u03baB signaling in a mouse model of Alzheimer\u2019s disease. Eur J Immunol 46:665\u2013676","journal-title":"Eur J Immunol"},{"key":"1631_CR71","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet 49:1373\u20131384","journal-title":"Nat Genet"},{"key":"1631_CR72","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3233\/JAD-151200","volume":"51","author":"SM Son","year":"2016","unstructured":"Son SM, Shin HJ, Byun J, Kook SY, Moon M, Chang YJ, Mook-Jung I (2016) Metformin facilitates Amyloid-\u03b2 generation by \u03b2- and \u03b3-Secretases via autophagy activation. J Alzheimers Dis 51:1197\u20131208","journal-title":"J Alzheimers Dis"},{"key":"1631_CR73","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/acscentsci.2c01369","volume":"9","author":"SH Son","year":"2023","unstructured":"Son SH, Lee NR, Gee MS, Song CW, Lee SJ, Lee SK, Lee Y, Kim HJ, Lee JK, Inn KS, Kim NJ (2023) Chemical knockdown of phosphorylated p38 Mitogen-Activated protein kinase (MAPK) as a novel approach for the treatment of Alzheimer\u2019s disease. ACS Cent Sci 9:417\u2013426","journal-title":"ACS Cent Sci"},{"key":"1631_CR74","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fnagi.2017.00139","volume":"9","author":"GJ Song","year":"2017","unstructured":"Song GJ, Suk K (2017) Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases. Front Aging Neurosci 9:139","journal-title":"Front Aging Neurosci"},{"key":"1631_CR75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1742-2094-8-92","volume":"8","author":"M Song","year":"2011","unstructured":"Song M, Jin J, Lim JE, Kou J, Pattanayak A, Rehman JA, Kim HD, Tahara K, Lalonde R, Fukuchi K (2011) TLR4 mutation reduces microglial activation, increases A\u03b2 deposits and exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation 8:92","journal-title":"J Neuroinflammation"},{"key":"1631_CR76","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","volume":"13","author":"W Song","year":"2017","unstructured":"Song W, Hooli B, Mullin K, Jin SC, Cella M, Ulland TK, Wang Y, Tanzi RE, Colonna M (2017) Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand\u2010dependent activation. Alzheimer\u2019s Dement 13:381\u2013387","journal-title":"Alzheimer\u2019s Dement"},{"key":"1631_CR77","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, West BL, Green KN (2016) Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain 139:1265\u20131281","journal-title":"Brain"},{"key":"1631_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnagi.2014.00171","volume":"6","author":"S Takeda","year":"2014","unstructured":"Takeda S, Sato N, Morishita R (2014) Systemic inflammation, blood-brain barrier vulnerability and cognitive\/non-cognitive symptoms in alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci 6:171","journal-title":"Front Aging Neurosci"},{"key":"1631_CR79","doi-asserted-by":"publisher","first-page":"e0291291","DOI":"10.1371\/journal.pone.0291291","volume":"18","author":"R Tanwani","year":"2023","unstructured":"Tanwani R, Danquah MO, Butris N, Saripella A, Yan E, Kapoor P, Englesakis M, Tang-Wai DF, Tartaglia MC, He D, Chung F (2023) Diagnostic accuracy of ascertain dementia 8-item questionnaire by participant and informant-A systematic review and meta-analysis. PLoS ONE 18:e0291291","journal-title":"PLoS ONE"},{"key":"1631_CR80","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.drudis.2022.01.016","volume":"27","author":"SA Tatulian","year":"2022","unstructured":"Tatulian SA (2022) Challenges and hopes for Alzheimer\u2019s disease. Drug Discov Today 27:1027\u20131043","journal-title":"Drug Discov Today"},{"key":"1631_CR81","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomed 14:5541\u20135554","journal-title":"Int J Nanomed"},{"key":"1631_CR82","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC-C, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A (2017a) TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170:649\u2013663 e613","journal-title":"Cell"},{"key":"1631_CR83","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A, Loginicheva E, Gilfillan S, Cella M, Virgin HW, Unanue ER, Wang Y, Artyomov MN, Holtzman DM, Colonna M (2017b) TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170:649\u2013663e613","journal-title":"Cell"},{"key":"1631_CR84","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00401-012-0987-3","volume":"123","author":"A Van der Jeugd","year":"2012","unstructured":"Van der Jeugd A, Hochgr\u00e4fe K, Ahmed T, Decker JM, Sydow A, Hofmann A, Wu D, Messing L, Balschun D, D\u2019Hooge R (2012) Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathol 123:787\u2013805","journal-title":"Acta Neuropathol"},{"key":"1631_CR85","doi-asserted-by":"crossref","unstructured":"Vargas-Mart\u00ednez AM (2024) Economic evaluations of technology-based interventions used to provide care support for people with mild dementia or mild cognitive impairment and their caregivers: A systematic review. J Alzheimers Dis 13872877241291070","DOI":"10.1177\/13872877241291070"},{"key":"1631_CR86","doi-asserted-by":"crossref","unstructured":"Vergara C, Sarah H, Suain V, Yilmaz Z, Decker R, Dries V, Boom A, Mansour S, Leroy K, Ando K, Brion J-P (2019) Amyloid-\u03b2 pathology enhances pathological fibrillary Tau seeding induced by alzheimer PHF in vivo. Acta Neuropathol 137","DOI":"10.1007\/s00401-018-1953-5"},{"key":"1631_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","volume":"7","author":"T Vogels","year":"2019","unstructured":"Vogels T, Murgoci A-N, Hrom\u00e1dka T (2019) Intersection of pathological Tau and microglia at the synapse. Acta Neuropathol Commun 7:109","journal-title":"Acta Neuropathol Commun"},{"key":"1631_CR88","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2217\/fnl.13.14","volume":"8","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue L-F (2013) Understanding the neurobiology of Cd200 and the Cd200 receptor: A therapeutic target for controlling inflammation in human brains?? Future Neurol 8:321\u2013332","journal-title":"Future Neurol"},{"key":"1631_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.expneurol.2008.09.003","volume":"215","author":"DG Walker","year":"2009","unstructured":"Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue L-F (2009) Decreased expression of CD200 and CD200 receptor in Alzheimer\u2019s disease: A potential mechanism leading to chronic inflammation. Exp Neurol 215:5\u201319","journal-title":"Exp Neurol"},{"key":"1631_CR90","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/bph.13394","volume":"173","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang Y, Peng Y, Hutchinson MR, Rice KC, Yin H, Watkins LR (2016) Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Br J Pharmacol 173:856\u2013869","journal-title":"Br J Pharmacol"},{"key":"1631_CR91","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1021\/acschemneuro.0c00445","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Vilekar P, Huang J, Weaver DF (2020) Furosemide as a probe molecule for the treatment of neuroinflammation in Alzheimer\u2019s disease. ACS Chem Neurosci 11:4152\u20134168","journal-title":"ACS Chem Neurosci"},{"key":"1631_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","volume":"52","author":"S Werneburg","year":"2020","unstructured":"Werneburg S, Jung J, Kunjamma RB, Ha SK, Luciano NJ, Willis CM, Gao G, Biscola NP, Havton LA, Crocker SJ, Popko B, Reich DS, Schafer DP (2020) Targeted complement Inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity 52:167\u2013182e167","journal-title":"Immunity"},{"key":"1631_CR93","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2005.04.019","volume":"383","author":"SB Wharton","year":"2005","unstructured":"Wharton SB, Williams GH, Stoeber K, Gelsthorpe CH, Baxter L, Johnson AL, Ince PG (2005) Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer-type pathology. Neurosci Lett 383:33\u201338","journal-title":"Neurosci Lett"},{"key":"1631_CR94","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.4049\/jimmunol.171.6.3034","volume":"171","author":"GJ Wright","year":"2003","unstructured":"Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T, Liu M-R, Brown MH, Sedgwick JD, Phillips JH, Barclay AN (2003) Characterization of the CD200 receptor family in mice and humans and their interactions with CD200 1. J Immunol 171:3034\u20133046","journal-title":"J Immunol"},{"key":"1631_CR95","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41232-022-00216-8","volume":"42","author":"C Wu","year":"2022","unstructured":"Wu C, Yang L, Feng S, Zhu L, Yang L, Liu TC, Duan R (2022) Therapeutic non-invasive brain treatments in Alzheimer\u2019s disease: recent advances and challenges. Inflamm Regen 42:31","journal-title":"Inflamm Regen"},{"key":"1631_CR96","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cbf.3623","volume":"39","author":"J Xue","year":"2021","unstructured":"Xue J, Jia P, Zhang D, Yao Z (2021) TTP488 ameliorates NLRP3-associated inflammation, viability, apoptosis, and ROS production in an Alzheimer\u2019s disease cell model by mediating the JAK1\/STAT3\/NF\u03baB\/IRF3 pathway. Cell Biochem Funct 39:555\u2013561","journal-title":"Cell Biochem Funct"},{"key":"1631_CR97","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-022-02401-5","volume":"19","author":"SS Zhang","year":"2022","unstructured":"Zhang SS, Zhu L, Peng Y, Zhang L, Chao FL, Jiang L, Xiao Q, Liang X, Tang J, Yang H, He Q, Guo YJ, Zhou CN, Tang Y (2022) Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP\/PS1 mice. J Neuroinflammation 19:34","journal-title":"J Neuroinflammation"},{"key":"1631_CR98","doi-asserted-by":"crossref","unstructured":"Zheng H, Jia L, Liu C-C, Rong Z, Zhong L, Yang L, Chen X-F, Fryer JD, Wang X, Zhang Y (2017) -w TREM2 promotes microglial survival by activating Wnt\/\u03b2-catenin pathway.\u00a0J Neurosci\u00a037:1772\u20131784","DOI":"10.1523\/JNEUROSCI.2459-16.2017"},{"key":"1631_CR99","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13041-020-0559-8","volume":"13","author":"Q Zhong","year":"2020","unstructured":"Zhong Q, Zou Y, Liu H, Chen T, Zheng F, Huang Y, Chen C, Zhang Z (2020) Toll-like receptor 4 deficiency ameliorates \u03b22-microglobulin induced age-related cognition decline due to neuroinflammation in mice. Mol Brain 13:20","journal-title":"Mol Brain"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01631-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01631-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01631-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T03:03:56Z","timestamp":1750907036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01631-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":98,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1631"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01631-9","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}